Pharmacokinetics of Treosulfan in Patients with Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Comparison of Two Formulations and Correlation with Clinical Outcomes

被引：0
|
作者：
Srivastava, Alok
Mohanan, Ezhilpavai
Illangeswaran, Raveen Stephen Stallon
Panetta, Carl
Lakshmi, Kavitha M.
Korula, Anu
Abraham, Aby
George, Biju
Mathews, Vikram
Balasubramanian, Poonkuzhali
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3219
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Influence of Pretransplantation Serum Ferritin on Children Beta-Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Ruan, Yongsheng
    Wu, Xuedong
    Feng, Xiaoqin
    He, Yuelin
    Li, Chunfu
    BLOOD, 2015, 126 (23)
  • [32] REJECTION AND SECOND HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH THALASSEMIA MAJOR
    Di Bartolomeo, E.
    Santarone, S.
    Bavaro, P.
    Di Carlo, P.
    Olioso, F.
    Papalinetti, G.
    Di Bartolomeo, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S29 - S29
  • [33] Treosulfan-Based Conditioning in Pediatric Hematopoietic Stem Cell Transplantation: A Prospective Study on Pharmacokinetics and Early Clinical Outcomes
    ten Brink, Marloes H.
    Bredius, Robbert G. M.
    Zwaveling, Juliette
    Ackaert, Oliver
    den Hartigh, Jan
    Smiers, Frans J.
    Guchelaar, Henk-Jan
    Lankester, Arjan
    BLOOD, 2014, 124 (21)
  • [34] COST COMPARISON OF HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CONVENTIONAL THERAPY FOR PATIENTS WITH THALASSEMIA MAJOR IN CHINA
    Tan, W.
    Li, C.
    Wu, X.
    He, Y.
    Feng, X.
    Liao, J.
    Liu, H.
    Xu, W.
    Ren, Y.
    HAEMATOLOGICA, 2015, 100 : 148 - 149
  • [35] Cost Comparison of Hematopoietic Stem Cell Transplantation and Conventional Therapy for Patients with Thalassemia Major in China
    Tan, Wanxia
    Li, Chunfu
    Wu, Xuedong
    He, Yuelin
    Feng, Xiaoqin
    Liao, Jianyun
    Liu, Huaying
    Xu, Wenfeng
    Ren, Yuqiong
    BLOOD, 2015, 126 (23)
  • [36] Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Rampal, Raajit K.
    Tamari, Roni
    Zhang, Nan
    McNamara, Caroline Jane
    Rapaport, Franck
    Litvin, Rivka
    Maloy, Molly A.
    Castro-Malaspina, Hugo
    Giralt, Sergio
    Weinberg, Rona Singer
    Mascarenhas, John
    Mesa, Ruben A.
    Rondelli, Damiano
    Dueck, Amylou C.
    Levine, Ross L.
    Gupta, Vikas
    Hoffman, Ronald
    BLOOD, 2016, 128 (22)
  • [37] Effect of pretransplantation serum activin A on outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation
    Hafez, Gehad H. F.
    Azzazi, Mohamed O.
    Hassan, Essam A.
    Mekawy, Mohamed A. M.
    El-Ghammaz, Amro M. S.
    Mohamed, Inas A. M.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (02): : 121 - 128
  • [38] COMPARISON OF IN-HOSPITAL CARDIOVASCULAR OUTCOMES BETWEEN PATIENTS UNDERGOING ALLOGENEIC VERSUS AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Krishan, Satyam
    Asad, Zain Ul Abideen
    Quiroga, Dionisia
    Ghazi, Sanam
    Quartermaine, Cooper J.
    Braunstein, Zachary
    Kola-Kehinde, Onaopepo O.
    Shaaban, Adnan
    Habib, Alma
    Khan, Sarah
    Cheng, Richard Kar-Hang
    Brammer, Jonathan
    Addison, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2490 - 2490
  • [39] Outcome of Second and Third Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Thalassemia
    Hussein, Ayad Ahmed
    Al-Zaben, Abdulhadi I.
    Khattab, Eman
    Haroun, Anas
    Frangoul, Haydar A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S249 - S249
  • [40] Population Pharmacokinetics of Cyclosporin in Patients Undergoing Allogeneic Stem Cell Transplantation
    Wilhelm, A. J.
    de Graaf, P.
    Veldkamp, A. I.
    Swart, E. L.
    Huijgens, P. C.
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 617 - 618
12345